Wakou Shokuhin Co., Ltd. (TYO:2813)
4,050.00
+50.00 (1.25%)
Jul 21, 2026, 9:16 AM JST
Wakou Shokuhin Revenue
In the fiscal year ending March 31, 2026, Wakou Shokuhin had annual revenue of 17.34B JPY with 6.73% growth. Wakou Shokuhin had revenue of 4.34B in the quarter ending March 31, 2026, with 10.13% growth.
Revenue
17.34B
Revenue Growth
+6.73%
P/S Ratio
0.58
Revenue / Employee
55.95M
Employees
310
Market Cap
9.98B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 17.34B | 1.09B | 6.73% |
| Mar 31, 2025 | 16.25B | 833.00M | 5.40% |
| Mar 31, 2024 | 15.42B | 1.91B | 14.18% |
| Mar 31, 2023 | 13.50B | 2.01B | 17.51% |
| Mar 31, 2022 | 11.49B | 1.52B | 15.19% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kitoku Shinryo | 180.84B |
| Delica Foods Holdings | 62.22B |
| NittoBest | 57.49B |
| Ahjikan | 51.43B |
| Hayashikane Sangyo | 45.59B |
| Yokohama Maruuo | 40.64B |
| Ichimasa Kamaboko | 35.30B |
| AFC-HD AMS Life Science | 33.20B |